UK volunteers to be infected with Covid-19 in first ‘human challenge’ vaccine trial
The aim is to discover the smallest amount of virus it takes to cause Covid-19 but there is some ethical controversy around such a trial
20 October 2020 - 19:00
London — Britain will help fund trials using a manufactured Covid-19 virus to deliberately infect young, healthy volunteers with the hope of accelerating the development of vaccines against it.
The government said on Tuesday it will invest £33.6m in the “human challenge” trials in partnership with Imperial College London, laboratory and trial services company hVIVO, and the Royal Free London NHS Foundation Trust...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.